What an eTMF system is, what regulators expect from it, the features to compare, and how to choose and implement the right eTMF for your clinical trials.

Fragmented clinical trial technology creates hidden costs through duplicated work, disconnected data and complex integrations. Discover how connected clinical research infrastructure brings CTMS, EDC, eTMF/eISF, clinical trial management and quality oversight together. Learn how AI-assisted clinical trial workflows and federated data management can reduce operational complexity, strengthen traceability and compliance, and give research teams more time to focus on science.

Before a clinical trial can begin, research teams can spend days turning a finalized protocol into trial configurations and EDC forms. myLaminin’s AI Clinical Trial Configuration Agent changes that. It reads the protocol and generates study steps, visit schedules, clinical variables and electronic data capture (EDC) forms in minutes. With more than 90% first-pass accuracy and human-in-the-loop review, researchers spend less time configuring trials and more time advancing rese

A practical guide to building a CTMS business case focusing on ROI, operational efficiency, visibility, accountability, compliance, and risk reduction. Learn how clinical research organizations, academic medical centers, universities, CROs, and research institutions can quantify the cost of manual trial management and evaluate how a modern CTMS can improve study start-up, site performance, audit readiness, and research operations nationwide.

Secure research collaboration is critical for universities, hospitals, CROs, biotech, and pharmaceutical organizations across Canada and the United States. As clinical trial data, IP, and regulatory information are shared, trust is the foundation. This article explores why secure research collaboration platforms matter and how myLaminin enables SOC 2 Type II compliant, patented collaboration across North America while protecting sensitive research data and accelerating discov

Five years ago, myLaminin began with a single idea. Today, it has evolved into a connected research ecosystem supporting the complete research lifecycle—from grant submission through publication. Discover how one conversation with a Canadian U15 university transformed our vision, how researchers co-designed our platform, and how myLaminin became a sovereign Research Data Management (RDM) and Clinical Trial Management System (CTMS) built for active science.

The new ICH E6(R3) guidelines are transforming clinical research worldwide, requiring Quality-by-Design, risk-based oversight, and validated digital systems. Discover how myLaminin's co-designed Clinical Trial Operations (CTOps) and CTMS platform helps research teams, principal investigators, administrators, and compliance professionals streamline operations, strengthen data integrity, improve audit readiness, and meet evolving global regulatory requirements with confidence.

Learn the differences between CTMS, EDC, and eTMF and how these essential clinical trial systems work together to improve research operations, data quality, regulatory compliance, and study efficiency. This guide explains the role of each platform, their integration across the clinical trial lifecycle, and how myLaminin's Research Data Management platform combines CTMS capabilities, participant management, eTMF, protocol management, audit trails, and 21 CFR Part 11 compliant

Discover how Clinical Trial Management Systems (CTMS) help academic research institutions improve compliance, reduce administrative burden, accelerate study start-up, and support ICH E6(R3)-aligned clinical trial operations.

earn how sponsors can manage protocol deviations, amendments, eTMF documentation, and regulatory compliance in multi-site clinical trials under evolving ICH E6(R3) expectations.

Clinical trial start-up delays continue to impact site activation, budgets, and timelines due to fragmented workflows across feasibility, contracting, IRB/REB approvals, training, and system readiness. This article explains how CTMS platforms, integrated research systems, and AI-driven automation reduce inefficiencies by centralizing processes, improving visibility, and accelerating trial activation across global clinical research environments.

Learn how ICH E6 (R3) is reshaping clinical trials through risk-based quality management, decentralized research oversight, data integrity, and continuous inspection readiness across global clinical research operations.

ICH E6 (R3) is reshaping clinical trial compliance across Canada, the U.S., EU, UK, and Australia. The updated Good Clinical Practice (GCP) guideline emphasizes Quality by Design, proactive risk management, audit trail traceability, sponsor oversight, informed consent, data integrity, and inspection readiness. myLaminin helps research teams and sponsors manage multi-site clinical trials with real-time oversight, CTQ monitoring, compliant eConsent, secure audit trails, and val

Multi-site clinical trials are widely used across North America to improve recruitment and accelerate timelines, but hidden operational risks often undermine success. Site variability, uneven engagement, communication breakdowns, and fragmented technology adoption create systemic inefficiencies that erode data quality and compliance. Without integrated oversight and standardized processes, complexity scales faster than control, increasing trial failure risk.

Poor clinical trial coordination drives costly delays, data integrity risks, and regulatory exposure across multi-site studies in Canada, the US, and globally. Fragmented systems, inconsistent documentation, and weak communication slow approvals, inflate Phase III costs, and erode patient trust. Integrated CTMS/CR/os platforms like myLaminin unify stakeholders, streamline workflows, strengthen compliance, and enable real-time oversight turning coordination into a competitive

Running clinical trials without a Clinical Trial Management System (CTMS) creates hidden operational burdens, from fragmented data and compliance risks to poor collaboration and reduced patient engagement. Disconnected tools like spreadsheets and email slow execution, increase errors, and threaten data integrity. A centralized CTMS streamlines workflows, ensures regulatory compliance, and improves trial efficiency, making it essential for scalable, secure, and successful clin

Spreadsheet-driven clinical trials introduce hidden risks in compliance, data integrity, and efficiency. While Excel remains a convenient tool, it often evolves into ungoverned infrastructure, creating version control issues, audit gaps, and costly delays. Modern CTMS platforms like myLaminin help research teams reduce spreadsheet dependency, strengthen governance, and streamline workflows without sacrificing flexibility in complex, data-intensive studies.

Digital twins are transforming personalized healthcare, but their impact depends on secure, interoperable data. myLaminin enables this with an integrated Research Data Management platform that unifies eConsent, CTMS, HL7 FHIR integration, and secure repositories. The result: compliant, AI-driven digital twin models that continuously learn, improve, and deliver more accurate clinical outcomes.

Modern clinical trials demand integrated systems to streamline workflows, centralize data, and ensure compliance. Fragmented tools slow research, increase costs, and risk errors, while platforms like myLaminin CTMS enhance efficiency, oversight, and data quality. By accelerating studies without compromising accuracy, modern clinical trial infrastructure supports faster, safer drug development and more reliable outcomes for patients.

University-led clinical trials are evolving as academic institutions adopt industry-grade infrastructure, centralized systems, and compliant data practices. Driven by growing complexity, AI, and digital health, universities are professionalizing research operations end-to-end. Platforms like myLaminin enable scalable, secure, and compliant trial execution bridging the gap between early discovery and full clinical development.